Get the Stockscreener App
5.44
5.56%
-0.32
Treace Medical Concepts Inc stock is traded at $5.44, with a volume of 316.40K.
It is down -5.56% in the last 24 hours and down -19.05% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
See More
Previous Close:
$5.76
Open:
$5.71
24h Volume:
316.40K
Relative Volume:
0.76
Market Cap:
$388.12M
Revenue:
$198.53M
Net Income/Loss:
$-63.68M
P/E Ratio:
-5.3219
EPS:
-1.0222
Net Cash Flow:
$-41.50M
1W Performance:
-11.83%
1M Performance:
-19.05%
6M Performance:
-27.03%
1Y Performance:
-10.53%
1-Day Range:
$5.43
$5.80
1-Week Range:
$5.43
$6.28
52-Week Range:
$4.54
$10.79
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
5.44 | 388.12M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
132.28 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
SYK
Stryker Corp
|
373.37 | 147.15B | 23.22B | 2.86B | 3.58B | 7.40 |
|
BSX
Boston Scientific Corp
|
101.73 | 146.97B | 17.55B | 2.03B | 2.72B | 1.37 |
|
MDT
Medtronic Plc
|
86.17 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
73.27 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
Grabar Law Office Investigates Claims on Behalf of - GlobeNewswire
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.16 Consensus Target Price from Analysts - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Rating of "Hold" by Brokerages - MarketBeat
Squarepoint Ops LLC Sells 52,890 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); Manhattan Associates, Inc. (NASDAQ: MANH); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT) - GlobeNewswire Inc.
California State Teachers Retirement System Sells 37,890 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Attention Long-Term Investors of Manhattan Associates, Inc. - GlobeNewswire
Attention Long-Term Investors of Manhattan Associates, Inc. (NASDAQ: MANH); Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) – Grabar Law Office is Investigating Claims - TradingView
Attention Long-Term Investors of AppLovin Corporation - GlobeNewswire
Kuehn Law Encourages Investors of Treace Medical Concepts, Inc. to Contact Law Firm - Kilgore News Herald
Securities Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (TMCI)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Treace Medical Concepts, Inc. Investors: Please contact the - GlobeNewswire
Securities Fraud Class Action Filed Against Treace Medical Concepts, Inc. (TMCI)Levi & Korsinsky Reminds Investors of June 10, 2025 - ACCESS Newswire
TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Lost Money on Treace Medical Concepts, Inc. (TMCI)? Join Class Action Before June 10, 2025Contact Levi & Korsinsky - ACCESS Newswire
Class Action Filed Against Treace Medical Concepts, Inc. - GlobeNewswire
Class Action Filed Against Treace Medical Concepts, Inc. (TMCI)June 10, 2025 Deadline to ... - Bluefield Daily Telegraph
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical - Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical ... - Bluefield Daily Telegraph
Treace Medical Concepts files patent infringement suit against Zimmer Biomet - Med-Tech Insights
Squarepoint Ops LLC Has $137,000 Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 10, 2025 in Treace Medical Concepts, Inc. LawsuitTMCI - marketscreener.com
Shareholders of Treace Medical Concepts, Inc. (TMCI): Protect Your Rights Before June 10, 2025Contact Levi & Korsinsky - ACCESS Newswire
TMCI FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securities Class ActionTMCI - ACCESS Newswire
FINAL TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Treace Medical Concepts, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FinancialContent
Recover Investment Losses: Levi & Korsinsky Files Class Action Against Treace Medical Concepts, Inc. (TMCI) - ACCESS Newswire
Treace Medical Concepts, Inc. Sued for Securities Law - GlobeNewswire
Treace Medical Concepts, Inc. Sued for Securities Law Violations – Investors Should Contact The ... - Bluefield Daily Telegraph
Treace Medical Concepts, Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – TMCI - TradingView
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical - StreetInsider
TMCI Investors Have Final Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
2025-06-09 | FINAL TMCI DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Treace Medical Concepts, Inc. Investors to Join the Class Action Lawsuit | NDAQ:TMCI | Press Release - Stockhouse
TMCI LAWSUIT ALERT: The Gross Law Firm Notifies Treace Medical Concepts, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire
2025-06-09 | Class Action Filed Against Treace Medical Concepts, Inc. (TMCI) Over Securities ViolationsContact Levi & Korsinsky Today | NDAQ:TMCI | Press Release - Stockhouse
TMCI FINAL DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, - GlobeNewswire
TMCI FINAL DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Treace Medical Concepts, Inc. ... - Bluefield Daily Telegraph
Treace Medical Concepts, Inc. (TMCI) LawsuitInvestors Urged to Contact Levi & Korsinsky Before June 10, 2025 - ACCESS Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical - StreetInsider
2025-06-08 | TMCI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Treace Medical Concepts, Inc. to Contact the Firm Today! | NDAQ:TMCI | Press Release - Stockhouse
Lost Money on Treace Medical Concepts, Inc. (TMCI)? Contact Levi & Korsinsky Before June 10, 2025 to Join Class Action - ACCESS Newswire
TMCI DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class ActionTMCI - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Treace Medical Concepts, Inc of Class Action Lawsuit and Upcoming DeadlinesTMCI - PR Newswire
Faruqi & Faruqi Reminds Treace Medical Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025TMCI - StreetInsider
Bank of America Corp DE Raises Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Did You Lose Money on Treace Medical Concepts, Inc. (TMCI)? Levi & Korsinsky Urges Investors to Act Before June 10, 2025 - ACCESS Newswire
TMCI Deadline: TMCI Investors with Losses in Excess of $100K Have Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit - Morningstar
2025-06-06 | Securities Fraud Class Action Filed Against Treace Medical Concepts, Inc. (TMCI)Levi & Korsinsky Reminds Investors of June 10, 2025 | NDAQ:TMCI | Press Release - Stockhouse
Levi & Korsinsky Notifies Treace Medical Concepts, Inc. (TMCI) Shareholders of Class Action Lawsuit And June 10, 2025 Deadline - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical - GlobeNewswire
Levi & Korsinsky Notifies Treace Medical Concepts, Inc. (TMCI) InvestorsLead Plaintiff Deadline on June 10, 2025 - ACCESS Newswire
TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - Kilgore News Herald
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):